Ever Supreme Bio Technology Co., Ltd 6712.TWO Stock
Ever Supreme Bio Technology Co., Ltd Price Chart
Ever Supreme Bio Technology Co., Ltd 6712.TWO Financial and Trading Overview
| Ever Supreme Bio Technology Co., Ltd stock price | 208.5 TWD |
| Previous Close | 192 TWD |
| Open | 193.5 TWD |
| Bid | 193 TWD x 0 |
| Ask | 193.5 TWD x 0 |
| Day's Range | 192.5 - 195 TWD |
| 52 Week Range | 140.95 - 252.35 TWD |
| Volume | 300.47K TWD |
| Avg. Volume | 1.99M TWD |
| Market Cap | 14.46B TWD |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 44.57275 |
| EPS (TTM) | 7.23 TWD |
| Forward Dividend & Yield | 1.99 (1.02%) |
| Ex-Dividend Date | May 29, 2023 |
| 1y Target Est | N/A |
6712.TWO Valuation Measures
| Enterprise Value | 14.46B TWD |
| Trailing P/E | 44.57275 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 8.069237 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Ever Supreme Bio Technology Co., Ltd Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | 15.37% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 252.35 TWD |
| 52 Week Low | 140.95 TWD |
| 50-Day Moving Average | 196.32 TWD |
| 200-Day Moving Average | 189.72 TWD |
6712.TWO Share Statistics
| Avg. Volume (3 month) | 1.99M TWD |
| Avg. Daily Volume (10-Days) | 532.9K TWD |
| Shares Outstanding | 74.93M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 44.34% |
| % Held by Institutions | 5.85% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 1.0482 |
| Last Split Factor | 1099.649:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | 8.38 TWD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | 4.33 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 23.918 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Ever Supreme Bio Technology Co., Ltd
| Country | Taiwan |
| State | N/A |
| City | Taichung |
| Address | No. 30, Keya Road |
| ZIP | N/A |
| Phone | 886 4 2325 2888 |
| Website | https://www.ever-supreme.com.tw |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Ever Supreme Bio Technology Co., Ltd engages in the research, development, and manufacture of drug products related to human mesenchymal stem cells and immune cells. Its products include UMC01, a drug candidate in Phase I clinical trials for the treatment of myocardial infarction and stroke; ADCV01, a drug candidate in Phase II clinical trials for the treatment of malignant brain tumor; CAR001, a chimeric antigen receptor immune cells product; and bone-marrow stem cells (BMSC), used to treat chronic stroke, degenerative osteoarthritis, and spinal cord injuries. The company was incorporated in 2016 and is based in Taichung, Taiwan.
Q&A For Ever Supreme Bio Technology Co., Ltd Stock
What is a current 6712.TWO stock price?
Ever Supreme Bio Technology Co., Ltd 6712.TWO stock price today per share is 208.5 TWD.
How to purchase Ever Supreme Bio Technology Co., Ltd stock?
You can buy 6712.TWO shares on the Taipei Exchange exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ever Supreme Bio Technology Co., Ltd?
The stock symbol or ticker of Ever Supreme Bio Technology Co., Ltd is 6712.TWO.
Which industry does the Ever Supreme Bio Technology Co., Ltd company belong to?
The Ever Supreme Bio Technology Co., Ltd industry is Biotechnology.
How many shares does Ever Supreme Bio Technology Co., Ltd have in circulation?
The max supply of Ever Supreme Bio Technology Co., Ltd shares is 73.34M.
What is Ever Supreme Bio Technology Co., Ltd Price to Earnings Ratio (PE Ratio)?
Ever Supreme Bio Technology Co., Ltd PE Ratio is 28.83817500 now.
What was Ever Supreme Bio Technology Co., Ltd earnings per share over the trailing 12 months (TTM)?
Ever Supreme Bio Technology Co., Ltd EPS is 7.23 TWD over the trailing 12 months.
Which sector does the Ever Supreme Bio Technology Co., Ltd company belong to?
The Ever Supreme Bio Technology Co., Ltd sector is Healthcare.